Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)

PHASE4RecruitingINTERVENTIONAL
Enrollment

870

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

February 29, 2028

Conditions
Vasoplegia
Interventions
DRUG

Midodrine

10 mg PO/NG q8h

DRUG

Placebo

Microcrystalline cellulose PO/NG 18h

Trial Locations (1)

T5R 0T1

RECRUITING

University of Alberta Hospital, Edmonton

All Listed Sponsors
collaborator

University Hospital Foundation

OTHER

collaborator

Institute of Health Economics, Canada

OTHER

collaborator

Alberta Health services

OTHER

lead

University of Alberta

OTHER